Interleukin-2 (Aldesleukin)

DRUG2 trials

Sponsors

M.D. Anderson Cancer Center, Cambridge University Hospitals NHS Foundation Trust

Conditions

CABGCoronary Artery DiseaseMelanomaMyocardial Infarction (MI)

Phase 1

IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic Melanoma

WithdrawnNCT01409187

M.D. Anderson Cancer CenterMelanoma

Start: 2011-10-31Updated: 2012-01-26

Unknown Phase

Low-dose Interleukin-2 After Myocardial Infarction to Investigate Effects on Tissue-resident Regulatory T Cells

RecruitingNCT07610538

Cambridge University Hospitals NHS Foundation TrustCABG, Coronary Artery Disease, Myocardial Infarction (MI)

Start: 2026-03-31End: 2028-12-01Target: 24Updated: 2026-05-28